Rivka Riven Kreitman, PhD, Senior Partner, KRDable Consulting
Rivka is a Senior Partner at KRDable consulting, a strategic drug development , product evaluation and partnerships consultancy.
Prior to this, she has been with Teva for 26 years during which she has held a number or roles ranging from BD (sourcing of new projects), running pharmacological studies assessing the mechanism of action of Copaxone (a drug for Multiple Sclerosis), Project leadership, managing the North America IR&D function and the Global Clinical Operation, Heading Branded Regulatory Affairs and heading the Global Innovative Research and Development (IR&D), focusing mainly on CNS, Autoimmune and Oncology and Heading Global Strategic Marketing, Biologics, Women’s health, Immunology and Cell therapy. In one of her last roles at Teva, Rivka was responsible for leading the search for new products, scientific evaluation of all opportunities and managing the collaboration with partners on early stage assets and technologies
Rivka earned her PhD at the Weizmann Institute of Science, Israel (Biochemistry) and postdoctoral work at Princeton University, NJ, US (Molecular Biology). Prior to joining Teva, she worked at Tel-Aviv University, Israel (Department of Physiology and Pharmacology, Sackler School of Medicine).
Rivka was a board member of TL Biopharmaceuticals, and is a Board member of the Philadelphia-Israel Chamber of Commerce and active member of its science and technology committee. She is also a member of several Scientific Advisory Boards